A Study of Brepocitinib in Adults with Active, Non-Infections, Non-Anterior Uveitis. (CLARITY)
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU)
ClinicalTrials.gov Identifier: NCT06431373
Principal Investigator: Assoc Prof. Mei-Ling Tay-Kearney
For further information about this study, you may visit Clinical Trial Registryn at www.clinicaltrials.gov/study/NCT06431373 or email lionsvisiontrials@lei.org.au.
